Matches 1 - 50 out of 222 1 2 3 4 5 >
Match Document Document Title
7601712 Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient  
A compound represented by formula (I) wherein the symbols in the formula are the same meanings as those in specification, salts thereof, solvates thereof, or prodrugs thereof binds to DP...
7423154 Asymmetric process for the preparation of diarylethylpiperazines derivatives and novel asymmetric diarylmethylamines as intermediates  
An asymmetric synthesis of diarylmethylpiperazines is described. The synthetic route enables preparation of a variety of enatiomerically pure amines with different N-alkyl groups. The invention...
7291621 Substituted biaryl amides C5a receptor modulators  
Substituted biaryl amides of Formula I are provided. Such compounds are ligands that may be used to modulate C 5 a receptor activity in vivo or in vitro, and are particularly useful in the...
7141674 Anti-inflammatory compounds  
This invention relates to anti-inflammatory compounds, methods of making such compounds and methods of using such compounds having the following structure:
7122561 Treatment of skin conditions  
The present invention provides piperine and analogues or derivatives thereof for the treatment of skin conditions treatable by stimulation of melanocyte proliferation, such as vitiligo, and also...
7119049 Oxathiinecarboxamides  
This invention relates to novel oxathiinecarboxamides of the formula (I) in which R, R 1 and m are as defined in the disclosure, to a plurality of processes for preparing these substances...
7078565 Benzamide derivatives as antagonists of orexin receptors  
Disclosed are phenyl-alkylene benzamides useful as orexin antagonists
7067551 Deacetylase inhibitors  
The present invention provides hydroxamate compounds which are deacetylase inhibitors. The compounds are suitable for pharmaceutical compositions having anti-proliferative properties.
7026339 Inhibitors of HCV NS5B polymerase  
The present invention relates to compounds, process for their synthesis, compositions and methods for the treatment and prevention of hepatitis C virus (HCV) infection. In particular, the present...
7019028 Endiandric acid H and its derivatives, process for their preparation and use thereof  
The invention relates to compounds of the formula (I) process for their preparation starting from the plant Beilschmiedia fulva , PLA 101037, and the use thereof for producing a medicament, in...
7019024 Pharmaceutical for treatment of neurological and neuropsychiatric disorders  
The invention provides a pharmaceutical for treatment of neurological and neuropsychiatric disorders comprising a compound of the formula: or a pharmaceutically acceptable salt thereof.
6878706 Cyanamides useful as reversible inhibitors of cysteine proteases  
Compounds according to the following formula (I): wherein the variables Q and R 1 to R 6 are as described herein, which reversibly inhibit the cysteine proteases, such as cathepsins K, S, F,...
6858648 Laetispicine and laetispicine analogues, methods of use and preparation  
A compound having the following Formula: wherein R1, R2, Z, and Y are defined herein, and methods of preparation and application for treating mental disorders and inflammation are provided...
6849649 N-phenpropylcyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase  
The invention relates to compounds of formula (I) for treating for example sexual dysfunction, wherein R 1 is optionally substituted C 1-6 alkyl, optionally substituted carbocyclyl, optionally...
6767921 Polymorphic forms of fasidotril, their methods of preparation and pharmaceutical compositions comprising them  
The subject of the present invention is the various polymorphic forms I, II, III, IV of benzyl (S,S)-2-(2-acetylsulphanylmethyl-3-benzo[1,3]dioxol-5-ylprop ionyl-amino)propionate, hereinafter...
6762318 Glucagon antagonists  
Novel compounds that act to antagonize the action of the glucagon peptide hormone on the glucagon receptor. More particularly, it relates to glucagon antagonists or inverse agonists.
6730705 Alkoximino acetic acid amides  
The invention relates to new alkoximinoacetic acid amides, a process for their preparation and their use as agents for combating pests.
6680391 Treatment of skin conditions  
The present invention provides piperine and analogues or derivatives thereof for the treatment of skin conditions treatable by stimulation of melanocyte proliferation, such as vitiligo, and also...
6677456 Pentacyclic taxan compound  
This invention is to provide a novel taxol derivative useful as an antitumor compound having respective substituent groups, represented by the following formula (I) which can be orally administered
6638970 Substituted alkylene diamine compounds  
Novel compounds of the general formula: and pharmaceutically acceptable acid addition salts thereof, wherein the compounds are useful in therapy to protect skeletal muscles against damage...
6603044 Phthalamide derivatives, or salt thereof agrohorticultural insecticide, and method for using the same  
The present invention provides a phthalamide derivative of the formula (I): wherein A 1 is (substituted) C 1 -C 8 alkylene, (substituted) C 3 -C 8 alkenylene, (substituted) C 3 -C 8 ...
6515124 Dehydroamino acids  
Aromatic dehydroamino acids are disclosed that are active as LFA-1 arnagonists This activity enables these compounds to prevent inflammation which is a consequence of T cell activation and...
6509379 Phenylacetic acid derivatives, process and intermediate products for their preparation, and their use as fungicides and pesticides  
Phenylacetic acid derivatives of the formula I where the variables are as disclosed herein, their salts, processes and intermediates for their preparation, and their use for controlling harmful...
6509369 Anti-inflammatory compounds  
This invention relates to anti-inflammatory compounds, methods of making such compounds and methods of using such compounds having the following structure:
6472414 Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method  
Novel compounds are provided which are inhibitors of MTP and thus are useful for lowering serum lipids and treating atherosclerosis and related diseases, and have the structure including...
6458801 Benzofurane derivatives, preparation method, use as medicines and pharmaceutical compositions containing same  
A compound of the formula wherein the substituents are as defined in the specification and its pharmaceutically acceptable salts and its prodrug useful for treating osteoporosis.
6344570 Substituted urea derivatives as cell adhesion inhibitors  
Compounds of formula (II) where R 1 is in the para or meta position and is (A); R 2 and R 3 are each independently selected from hydrogen, nitro, C 1-6 alkyl, C 3-6 cycloalkyl, C 2-6 alkenyl,...
6340704 Cell differentiation inducing amide derivatives, their production and use  
The present invention provides a compound represented by the formula: wherein R 1 is an amino group which may be substituted; R 2 is a hydrogen atom or a lower alkyl group which may be...
6323227 Substituted N-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides  
This invention relates to compounds of formula ##STR1## which inhibit Factor Xa, to pharmaceutical compositions containing the compounds, and to the use of the compounds for the treatment of...
6306873 Substituted β-thiocarboxylic acids  
This invention relates to compounds of general formula (I): ##STR1## in which Ar is a group selected from: ##STR2## A1, A2, B, C, D, E, Q1-Q3, R1-R9, Z1 and Z2 are as defined in the disclosure, and...
6303799 Polynucleotide crosslinking agents  
Novel aryl derivatives comprising an aryl olefin moiety linked to a non-nucleosidic backbone moiety are disclosed. The resulting molecules are typically used as photoactivated crosslinking groups...
6214870 Dioxocyclopentyl hydroxamic acids  
The present invention relates to dioxocyclopentyl hydroxamide derivatives of the formula ##STR1## wherein X, Z and Q are as defined in the specification, and to pharmaceutical compositions and...
6214869 Heterocyclic cis cyclopropane derivatives as melatonergic agents  
There is provided a novel series of cis cyclopropane compounds of Formula I ##STR1## wherein R 1 , R 2 , R 3 , R 4 , X, Y, Z and m are as defined herein which bind to the human melatonin receptor...
6214859 Ethylamine derivatives  
Ethylamine derivatives of the formula (I): ##STR1## (wherein R 1 is hydrogen, hydroxyl, lower alkoxy or halogen; R 2 is alkyl having 2 to 5 carbon atoms; R 3 is hydrogen, alkyl having 2 to 5...
6211240 O-benzyl oxime ether derivatives and their use as pesticides  
Compounds of the formula I ##STR1## in which Y is hydrogen, C 1 -C 4 alkyl, C 1 -C 4 alkoxy, OH, CN, NO 2 , Si(CH 3 ) 3 , CF 3 or halogen, Z is a group a) ##STR2## R 1 is hydrogen, C...
6207686 Endothelin antagonists  
A compound of formula (I), in which: R 1 is lower alkyl, cyclo(lower)alkyl, optionally substituted aryl, optionally substituted heterocyclic group, cyclo(lower)alkyl(lower)alkyl, or...
6194448 N, N-disubstituted amides that inhibit the binding of integrins to their receptors  
A method for the inhibition of the binding of α 4 β 1 integrin to its receptors, for example VCAM-1 (vascular cell adhesion molecule-1) and fibronectin; compounds that inhibit this binding;...
6150416 Nanomolar, non-peptide inhibitors of cathepsin D  
The present invention provides non-peptide cathepsin D binding compounds and methods for using such compounds in the detection, labelling and inhibition of cathepsin D.
6130251 Alkoximinoacetic acid amides  
The invention relates to new alkoximinoacetic acid amides, a process for their preparation and their use as agents for combating pests.
6040339 Urea derivatives having ACAT inhibitory activity, their preparation and their therapeutic and prophylactic use  
Compounds of formula (I): ##STR1## wherein: R 1 is alkyl; R 2a , R 2b , R 2c and R 2d are the same or different and each is hydrogen, optionally substituted alkyl or various other organic...
6011059 Acyl guanidine sodium/proton exchange inhibitors and method  
Acyl guanidines are provided which are sodium/proton exchange (NHE) inhibitors which have the structure ##STR1## wherein n is 1 to 5; X is N or C--R 5 wherein R 5 is H, halo, alkenyl, alkynyl,...
5998667 Substituted biphenyl oxazolines  
The invention relates to new substituted biphenyloxazolines of the formula (I) ##STR1## in which R 1 represents C 1 -C 6 -halogenoalkylthio and R 2 represents hydrogen, or R 1 and R 2 ...
5981571 Benzodioxa alkylene ethers as melatonergic agents  
Novel derivatives of benzodioxa alkylene ethers are provided which are useful as melatonergic agents.
5948778 Difluoro statone antiviral analogs  
This invention relates to novel statone antiviral analogs, to the processes and intermediates useful for their preparation and to their use as antiviral agents.
5945548 Process for the synthesis of α-substituted acrylic acids and their application  
Process for the synthesis of α-substituted acrylic acids of general formula (I) and their application to the synthesis of N-(mercaptoacyl)aminoacid derivatives of formula (II). ##STR1##
5919954 Stereoselective process for producing dihydro-2,3-benzodiazepine derivatives  
A process for stereoselectively forming N-substituted dihydro-2,3 benzodiazepines which are useful as AMPA receptor antagonists. The process includes an opening reduction step which sets the...
5880147 Amide derivatives having ACAT inhibitory activity, their preparation and their therapeutic and prohylactic use  
Compounds of formula (I): ##STR1## wherein: R 1 is alkyl; R 2a , R 2b , R 2c and R 2d are the same or different and each is hydrogen, optionally substituted alkyl, --(CO)--B 1 (wherein B 1 ...
5846956 Amino acids derivatives, the process for their preparation and their applications to therapy  
Amino acid derivatives of formula (Ia) and (Ib) and pro-drugs thereof containing a group responsible for chelating the zinc atom of enkephalinase and angiotensin convertase enzymes are disclosed as...
5801197 Rotamase enzyme activity inhibitors  
This invention relates to the method of using specially formulated neurotrophic pipecolic acid derivative compounds having an affinity for FKBP-type immunophilins as inhibitors of the enzyme...
5770620 Aryl acrylic acid derivatives useful as protein tyrosine phosphatase inhibitors  
The present invention provides novel protein tyrosine phosphatase modulating compounds having an aryl acrylic acid structure, compositions comprising the compounds, and methods of making and using...
Matches 1 - 50 out of 222 1 2 3 4 5 >